Authors:
COOPER DS
SPECKER B
HO M
SPERLING M
LADENSON PW
ROSS DS
AIN KB
BIGOS ST
BRIERLEY JD
HAUGEN BR
KLEIN I
ROBBINS J
SHERMAN SI
TAYLOR T
MAXON HR
Citation: Ds. Cooper et al., THYROTROPIN SUPPRESSION AND DISEASE PROGRESSION IN PATIENTS WITH DIFFERENTIATED THYROID-CANCER - RESULTS FROM THE NATIONAL THYROID-CANCER TREATMENT COOPERATIVE REGISTRY, Thyroid, 8(9), 1998, pp. 737-744
Authors:
SHERMAN SI
BRIERLEY JD
SPERLING M
AIN KB
BIGOS ST
COOPER DS
HAUGEN BR
HO MN
KLEIN I
LADENSON PW
ROBBINS J
ROSS DS
SPECKER B
TAYLOR T
MAXON HR
Citation: Si. Sherman et al., PROSPECTIVE MULTICENTER STUDY OF THYROID-CARCINOMA TREATMENT - INITIAL ANALYSIS OF STAGING AND OUTCOME, Cancer, 83(5), 1998, pp. 1012-1021
Authors:
CHEN H
NICOL TL
ZEIGER MA
DOOLEY WC
LADENSON PW
COOPER DS
RINGEL M
PARKERSON S
ALLO M
UDELSMAN R
Citation: H. Chen et al., HURTHLE CELL NEOPLASMS OF THE THYROID - ARE THERE FACTORS PREDICTIVE OF MALIGNANCY, Annals of surgery, 227(4), 1998, pp. 542-546
Citation: Nr. Powe et al., DECISION-ANALYSIS IN ENDOCRINOLOGY AND METABOLISM, Endocrinology and metabolism clinics of North America, 26(1), 1997, pp. 89
Citation: Md. Danese et al., MORE ON SCREENING FOR MILD THYROID FAILURE - REPLY, JAMA, the journal of the American Medical Association, 277(6), 1997, pp. 459-459
Authors:
LADENSON PW
BRAVERMAN LE
MAZZAFERRI EL
BRUCKERDAVIS F
COOPER DS
GARBER JR
WONDISFORD FE
DAVIES TF
DEGROOT LJ
DANIELS GH
ROSS DS
WEINTRAUB BD
Citation: Pw. Ladenson et al., COMPARISON OF ADMINISTRATION OF RECOMBINANT HUMAN THYROTROPIN WITH WITHDRAWAL OF THYROID-HORMONE FOR RADIOACTIVE IODINE SCANNING IN PATIENTS WITH THYROID-CARCINOMA, The New England journal of medicine, 337(13), 1997, pp. 888-896
Authors:
SHERMAN SI
RINGEL MD
SMITH MJ
KOPELEN HA
ZOGHBI WA
LADENSON PW
Citation: Si. Sherman et al., AUGMENTED HEPATIC AND SKELETAL THYROMIMETIC EFFECTS OF TIRATRICOL IN COMPARISON WITH LEVOTHYROXINE, The Journal of clinical endocrinology and metabolism, 82(7), 1997, pp. 2153-2158
Authors:
ELDEIRY SS
NAIDU S
BLEVINS LS
LADENSON PW
Citation: Ss. Eldeiry et al., ASSESSMENT OF ADRENAL-FUNCTION IN WOMEN HETEROZYGOUS FOR ADRENOLEUKODYSTROPHY, The Journal of clinical endocrinology and metabolism, 82(3), 1997, pp. 856-860
Citation: Md. Danese et al., SCREENING FOR MILD THYROID FAILURE AT THE PERIODIC HEALTH EXAMINATION- A DECISION AND COST-EFFECTIVENESS ANALYSIS, JAMA, the journal of the American Medical Association, 276(4), 1996, pp. 285-292
Citation: Md. Danese et al., SHOULD PHYSICIANS SCREEN FOR MILD THYROID FAILURE - REPLY, JAMA, the journal of the American Medical Association, 276(19), 1996, pp. 1550-1551
Citation: Md. Ringel et Pw. Ladenson, DIAGNOSTIC-ACCURACY OF I-131 SCANNING WITH RECOMBINANT HUMAN THYROTROPIN VERSUS THYROID-HORMONE WITHDRAWAL IN A PATIENT WITH METASTATIC THYROID-CARCINOMA AND HYPOPITUITARISM, The Journal of clinical endocrinology and metabolism, 81(5), 1996, pp. 1724-1725
Citation: Pw. Ladenson, OPTIMAL LABORATORY TESTING FOR DIAGNOSIS AND MONITORING OF THYROID-NODULES, GOITER, AND THYROID-CANCER, Clinical chemistry, 42(1), 1996, pp. 183-187
Authors:
TIELENS ET
FORDER JR
CHATHAM JC
MARRELLI SP
LADENSON PW
Citation: Et. Tielens et al., ACUTE L-TRIIODOTHYRONINE ADMINISTRATION POTENTIATES INOTROPIC RESPONSES TO BETA-ADRENERGIC STIMULATION IN THE ISOLATED-PERFUSED RAT-HEART, Cardiovascular Research, 32(2), 1996, pp. 306-310
Authors:
SINGER PA
COOPER DS
DANIELS GH
LADENSON PW
GREENSPAN FS
LEVY EG
BRAVERMAN LE
CLARK OH
MCDOUGALL IR
AIN KV
DORFMAN SG
Citation: Pa. Singer et al., TREATMENT GUIDELINES FOR PATIENTS WITH THYROID-NODULES AND WELL-DIFFERENTIATED THYROID-CANCER, Archives of internal medicine, 156(19), 1996, pp. 2165-2172
Citation: Si. Sherman et al., CLINICAL AND SOCIOECONOMIC PREDISPOSITIONS TO COMPLICATED THYROTOXICOSIS - A PREDICTABLE AND PREVENTABLE SYNDROME, The American journal of medicine, 101(2), 1996, pp. 192-198
Authors:
SINGER PA
COOPER DS
LEVY EG
LADENSON PW
BRAVERMAN LE
DANIELS G
GREENSPAN FS
MCDOUGALL IR
NIKOLAI TF
Citation: Pa. Singer et al., TREATMENT GUIDELINES FOR PATIENTS WITH HYPERTHYROIDISM AND HYPOTHYROIDISM, JAMA, the journal of the American Medical Association, 273(10), 1995, pp. 808-812
Authors:
OPPENHEIMER JH
BRAVERMAN LE
TOFT A
JACKSON IM
LADENSON PW
Citation: Jh. Oppenheimer et al., THYROID-HORMONE TREATMENT - WHEN AND WHAT, The Journal of clinical endocrinology and metabolism, 80(10), 1995, pp. 2873-2883
Authors:
SHERMAN SI
TIELENS ET
SOSTRE S
WHARAM MD
LADENSON PW
Citation: Si. Sherman et al., CLINICAL UTILITY OF POSTTREATMENT RADIOIODINE SCANS IN THE MANAGEMENTOF PATIENTS WITH THYROID-CARCINOMA, The Journal of clinical endocrinology and metabolism, 78(3), 1994, pp. 629-634
Authors:
BLEVINS LS
SHANKROFF J
MOSER HW
LADENSON PW
Citation: Ls. Blevins et al., ELEVATED PLASMA ADRENOCORTICOTROPIN CONCENTRATION AS EVIDENCE OF LIMITED ADRENOCORTICAL RESERVE IN PATIENTS WITH ADRENOMYELONEUROPATHY, The Journal of clinical endocrinology and metabolism, 78(2), 1994, pp. 261-265
Authors:
CATUREGLI P
KUPPERS RC
MARIOTTI S
BUREK CL
PINCHERA A
LADENSON PW
ROSE NR
Citation: P. Caturegli et al., IGG SUBCLASS DISTRIBUTION OF THYROGLOBULIN ANTIBODIES IN PATIENTS WITH THYROID-DISEASE, Clinical and experimental immunology, 98(3), 1994, pp. 464-469